Versant Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Versant Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-85	Closed	-$11K	–	1624
2020 Q3	$11K	Hold	85	–	–	﹤0.01%	638
2020 Q2	$8K	Hold	85	–	–	﹤0.01%	719
2020 Q1	$3K	Buy	85 +4	+5%	+$256	﹤0.01%	970
2019 Q4	$5K	Hold	81	–	–	﹤0.01%	965
2019 Q3	$4K	Buy	+81	New	+$4.31K	﹤0.01%	1059
2019 Q2	–	Sell	-6	Closed	–	–	1834
2019 Q1	$0	Buy	+6	New	+$276	﹤0.01%	1820

Versant Capital Management's MYOK Position: Q4 2020 in Review

Versant Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 85 shares — an estimated $11K sold.

Versant Capital Management first reported a position in MYOK in Q1 2019 and held it in 6 quarters. The position peaked at $11K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Versant Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Versant Capital Management sold 85 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $11K.
Versant Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 6 quarters.
Versant Capital Management's MyoKardia, Inc. Common Stock position peaked at $11K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Versant Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.